Equine Atopic Disease Symptomatic Therapy and Allergen-Specific Immunotherapy

Wayne Rosenkrantz, Stephen D White

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Equine atopic skin disease is typically considered a lifelong disease that requires chronic management. Management strategies include allergen avoidance, topical therapy, systemic medications, such as antihistamines, glucocorticoids, and tricyclic antidepressants, or a combination of all of these. Some of these options have undesirable adverse effects and limitations on usage in competition sporting events and avoidance of allergens is often impractical. Allergen-specific immunotherapy (ASIT) is therefore a practical option for many cases. There are a variety of different topical repellents and insecticides available to use to control insect allergens. As seen in other species with atopic dermatitis, topical therapy in the horse can provide emollient, moisturizing, and antipruritic effects and may improve epidermal barrier function.

Original languageEnglish (US)
Title of host publicationVeterinary Allergy
PublisherWiley Blackwell
Pages360-370
Number of pages11
ISBN (Electronic)9781118738818
ISBN (Print)9780470672419
DOIs
StatePublished - Jan 1 2013

Fingerprint

Horse Diseases
Immunologic Desensitization
immunotherapy
allergens
Allergens
horses
therapeutics
Horses
Antipruritics
Emollients
Insect Control
Tricyclic Antidepressive Agents
Histamine Antagonists
Atopic Dermatitis
antihistamines
Insecticides
Skin Diseases
antidepressants
Glucocorticoids
atopic dermatitis

Keywords

  • Allergen-specific immunotherapy (ASIT)
  • Antihistamines
  • Equine atopic disease
  • Glucocorticoids
  • Insect control
  • Mould control
  • Symptomatic therapy
  • Systemic therapy
  • Topical therapy

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Equine Atopic Disease Symptomatic Therapy and Allergen-Specific Immunotherapy. / Rosenkrantz, Wayne; White, Stephen D.

Veterinary Allergy. Wiley Blackwell, 2013. p. 360-370.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rosenkrantz, Wayne ; White, Stephen D. / Equine Atopic Disease Symptomatic Therapy and Allergen-Specific Immunotherapy. Veterinary Allergy. Wiley Blackwell, 2013. pp. 360-370
@inbook{3c3eac5e316a4b8697e968b4e3d0882a,
title = "Equine Atopic Disease Symptomatic Therapy and Allergen-Specific Immunotherapy",
abstract = "Equine atopic skin disease is typically considered a lifelong disease that requires chronic management. Management strategies include allergen avoidance, topical therapy, systemic medications, such as antihistamines, glucocorticoids, and tricyclic antidepressants, or a combination of all of these. Some of these options have undesirable adverse effects and limitations on usage in competition sporting events and avoidance of allergens is often impractical. Allergen-specific immunotherapy (ASIT) is therefore a practical option for many cases. There are a variety of different topical repellents and insecticides available to use to control insect allergens. As seen in other species with atopic dermatitis, topical therapy in the horse can provide emollient, moisturizing, and antipruritic effects and may improve epidermal barrier function.",
keywords = "Allergen-specific immunotherapy (ASIT), Antihistamines, Equine atopic disease, Glucocorticoids, Insect control, Mould control, Symptomatic therapy, Systemic therapy, Topical therapy",
author = "Wayne Rosenkrantz and White, {Stephen D}",
year = "2013",
month = "1",
day = "1",
doi = "10.1002/9781118738818.ch54",
language = "English (US)",
isbn = "9780470672419",
pages = "360--370",
booktitle = "Veterinary Allergy",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Equine Atopic Disease Symptomatic Therapy and Allergen-Specific Immunotherapy

AU - Rosenkrantz, Wayne

AU - White, Stephen D

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Equine atopic skin disease is typically considered a lifelong disease that requires chronic management. Management strategies include allergen avoidance, topical therapy, systemic medications, such as antihistamines, glucocorticoids, and tricyclic antidepressants, or a combination of all of these. Some of these options have undesirable adverse effects and limitations on usage in competition sporting events and avoidance of allergens is often impractical. Allergen-specific immunotherapy (ASIT) is therefore a practical option for many cases. There are a variety of different topical repellents and insecticides available to use to control insect allergens. As seen in other species with atopic dermatitis, topical therapy in the horse can provide emollient, moisturizing, and antipruritic effects and may improve epidermal barrier function.

AB - Equine atopic skin disease is typically considered a lifelong disease that requires chronic management. Management strategies include allergen avoidance, topical therapy, systemic medications, such as antihistamines, glucocorticoids, and tricyclic antidepressants, or a combination of all of these. Some of these options have undesirable adverse effects and limitations on usage in competition sporting events and avoidance of allergens is often impractical. Allergen-specific immunotherapy (ASIT) is therefore a practical option for many cases. There are a variety of different topical repellents and insecticides available to use to control insect allergens. As seen in other species with atopic dermatitis, topical therapy in the horse can provide emollient, moisturizing, and antipruritic effects and may improve epidermal barrier function.

KW - Allergen-specific immunotherapy (ASIT)

KW - Antihistamines

KW - Equine atopic disease

KW - Glucocorticoids

KW - Insect control

KW - Mould control

KW - Symptomatic therapy

KW - Systemic therapy

KW - Topical therapy

UR - http://www.scopus.com/inward/record.url?scp=85018260426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018260426&partnerID=8YFLogxK

U2 - 10.1002/9781118738818.ch54

DO - 10.1002/9781118738818.ch54

M3 - Chapter

AN - SCOPUS:85018260426

SN - 9780470672419

SP - 360

EP - 370

BT - Veterinary Allergy

PB - Wiley Blackwell

ER -